NASDAQ
Clarus Therapeutics Holdings, Inc. (CRXTQ) has a fcf yield of -18389.10% as of Tuesday, August 4, 2026. This represents a 225.23% decrease compared to its 12-month average of -5654.14%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.